. (OCAT)
$8.47 - (-)
Market Cap: -
As of 12/31/18 12:00 AM EST. Market closed.
. (OCAT)
$8.47
- (-)
Market Cap: -
As of 12/31/18 12:00 AM EST. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$8.47
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$8.47
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Lanza Robert | Chief Scientific Officer | Feb 10, 2016 | Option Exercise | $8.50 | 231,509 | 1,967,827 | 0 | Feb 11, 2016, 04:36 PM |
| Myles Edward H | COO & CFO | Feb 10, 2016 | Option Exercise | $8.50 | 56,000 | 476,000 | 0 | Feb 11, 2016, 04:35 PM |
| PERRY GREGORY D | Director | Feb 10, 2016 | Option Exercise | $8.50 | 21,417 | 182,045 | 0 | Feb 11, 2016, 04:34 PM |
| LEVY BRIAN | Director | Feb 10, 2016 | Option Exercise | $8.50 | 12,500 | 106,250 | 0 | Feb 11, 2016, 04:33 PM |
| Jooste H Le Roux | SVP of Bus Development & CCO | Feb 10, 2016 | Option Exercise | $8.50 | 25,000 | 212,500 | 0 | Feb 11, 2016, 04:33 PM |
| SHAPIRO ALAN C | Director | Feb 10, 2016 | Option Exercise | $8.50 | 283,266 | 2,407,761 | 0 | Feb 11, 2016, 04:32 PM |
| Anglade Eddy | Chief Medical Officer | Feb 10, 2016 | Option Exercise | $8.50 | 56,000 | 476,000 | 0 | Feb 11, 2016, 04:30 PM |
| Heffernan Michael Thomas | Director | Feb 10, 2016 | Option Exercise | $8.50 | 31,000 | 263,500 | 0 | Feb 11, 2016, 04:29 PM |
| LOSHITZER ZOHAR | Director | Feb 10, 2016 | Option Exercise | $8.50 | 21,834 | 185,589 | 0 | Feb 11, 2016, 04:28 PM |
| LANGER ROBERT | Director | Feb 10, 2016 | Option Exercise | $8.50 | 51,000 | 433,500 | 0 | Feb 11, 2016, 04:27 PM |
| Wotton Paul K | President and CEO | Feb 10, 2016 | Option Exercise | $8.50 | 277,500 | 2,358,750 | 0 | Feb 11, 2016, 04:26 PM |
| Lanza Robert | Chief Scientific Officer | Nov 10, 2015 | Sale | $8.31 | 35,000 | 290,950 | 216,509 | Nov 10, 2015, 04:04 PM |
| Wotton Paul K | President and CEO | Jul 30, 2015 | Option Exercise | $4.23 | 32,500 | 137,475 | 267,500 | Jul 31, 2015, 04:14 PM |
| Lanza Robert | Chief Scientific Officer | Sep 10, 2014 | Sale | $12.53 | 8,930 | 111,900 | 179,439 | Sep 11, 2014, 09:15 AM |
| Lanza Robert | Chief Scientific Officer | Sep 08, 2014 | Sale | $10.05 | 15,000 | 150,700 | 194,439 | Sep 09, 2014, 04:09 PM |
| Lanza Robert | Chief Scientific Officer | Sep 03, 2014 | Sale | $9.00 | 10,000 | 90,000 | 199,439 | Sep 04, 2014, 04:03 PM |
| Lanza Robert | Chief Scientific Officer | Sep 02, 2014 | Sale | $8.42 | 15,000 | 126,250 | 214,439 | Sep 04, 2014, 04:03 PM |
| Lanza Robert | Chief Scientific Officer | Jul 07, 2014 | Sale | $0.08 | 745,000 | 59,600 | 22,443,822 | Jul 07, 2014, 04:29 PM |
| Lanza Robert | Chief Scientific Officer | Jul 03, 2014 | Sale | $0.08 | 755,000 | 60,400 | 23,188,822 | Jul 07, 2014, 04:29 PM |
| Rabin Gary H | CEO & CFO | Feb 07, 2011 | Sale | $0.19 | 250,000 | 48,700 | 17,865,964 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 29, 2012 | Sale | $0.08 | 24,500 | 1,960 | 10,350,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Aug 10, 2011 | Sale | $0.16 | 135,100 | 21,940 | 15,422,871 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Oct 23, 2012 | Sale | $0.07 | 650,000 | 45,565 | 7,000,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Jan 23, 2012 | Sale | $0.18 | 625,000 | 109,500 | 11,549,972 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 25, 2012 | Sale | $0.08 | 80,000 | 6,440 | 10,374,501 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Aug 09, 2011 | Sale | $0.17 | 667,000 | 110,322 | 15,557,971 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Oct 22, 2012 | Sale | $0.07 | 350,000 | 25,025 | 7,650,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Oct 14, 2011 | Sale | $0.14 | 720,920 | 104,389 | 12,174,972 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 24, 2012 | Sale | $0.08 | 95,471 | 7,666 | 10,454,501 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 04, 2011 | Sale | $0.19 | 266,898 | 51,938 | 16,224,971 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Sep 06, 2012 | Sale | $0.08 | 391,444 | 32,098 | 8,000,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Oct 13, 2011 | Sale | $0.14 | 787,429 | 111,657 | 12,895,892 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 14, 2012 | Sale | $0.07 | 388,090 | 26,584 | 10,549,972 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Apr 26, 2011 | Sale | $0.18 | 733,102 | 130,126 | 16,491,869 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Sep 05, 2012 | Sale | $0.08 | 608,556 | 50,023 | 8,391,445 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Oct 12, 2011 | Sale | $0.15 | 491,650 | 71,388 | 13,683,321 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 11, 2012 | Sale | $0.07 | 290,000 | 20,793 | 10,938,062 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Feb 28, 2011 | Sale | $0.17 | 390,993 | 68,072 | 17,224,971 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Aug 27, 2012 | Sale | $0.08 | 1,000,000 | 78,400 | 9,000,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Aug 12, 2011 | Sale | $0.17 | 539,987 | 91,690 | 14,174,971 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 07, 2012 | Sale | $0.08 | 122,000 | 9,821 | 11,228,062 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Feb 09, 2011 | Sale | $0.19 | 250,000 | 47,225 | 17,615,964 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Jun 15, 2012 | Sale | $0.07 | 350,000 | 25,375 | 10,000,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Aug 11, 2011 | Sale | $0.16 | 707,913 | 115,956 | 14,714,958 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | Jan 10, 2013 | Sale | $0.08 | 1,000,000 | 79,200 | 6,000,001 | Apr 15, 2013, 08:33 AM |
| Rabin Gary H | CEO & CFO | May 03, 2012 | Sale | $0.08 | 199,910 | 16,653 | 11,350,062 | Apr 15, 2013, 08:33 AM |
| Lanza Robert | Chief Scientific Officer | Dec 14, 2012 | Sale | $0.06 | 1,338,490 | 78,617 | 23,937,575 | Feb 05, 2013, 03:58 PM |
| Lanza Robert | Chief Scientific Officer | Dec 14, 2012 | Sale | $0.06 | 1,338,490 | 78,617 | 27,794,717 | Dec 18, 2012, 06:59 PM |
| Lanza Robert | Chief Scientific Officer | Jul 31, 2012 | Sale | $0.08 | 500,000 | 40,000 | 26,529,003 | Aug 01, 2012, 08:13 AM |
| Lanza Robert | Chief Scientific Officer | Jul 30, 2012 | Sale | $0.08 | 1,500,000 | 120,942 | 27,917,296 | Aug 01, 2012, 08:13 AM |
| Rabin Gary H | CEO & CFO | Jun 11, 2012 | Sale | $0.08 | 175,029 | 13,127 | 14,912,401 | Jun 19, 2012, 08:29 PM |
| Rabin Gary H | CEO & CFO | Jun 14, 2012 | Sale | $0.07 | 350,000 | 25,095 | 14,262,401 | Jun 19, 2012, 08:29 PM |
| Rabin Gary H | CEO & CFO | Jun 13, 2012 | Sale | $0.07 | 300,000 | 21,240 | 14,612,401 | Jun 19, 2012, 08:29 PM |
| Lanza Robert | Chief Scientific Officer | Jan 24, 2012 | Sale | $0.19 | 6,658,300 | 1,277,728 | 25,957,575 | Jan 25, 2012, 07:17 PM |
| Lanza Robert | Chief Scientific Officer | Jan 23, 2012 | Sale | $0.18 | 1,000,000 | 175,400 | 32,615,875 | Jan 25, 2012, 07:17 PM |
| Lanza Robert | Chief Scientific Officer | Sep 29, 2011 | Sale | $0.15 | 608,225 | 93,058 | 33,615,875 | Sep 30, 2011, 06:12 PM |
| Lanza Robert | Chief Scientific Officer | Sep 28, 2011 | Sale | $0.15 | 118,080 | 17,840 | 34,332,180 | Sep 30, 2011, 06:12 PM |
| Lanza Robert | Chief Scientific Officer | Jun 21, 2011 | Option Exercise | $0.05 | 750,000 | 37,500 | 19,342,180 | Jun 30, 2011, 07:15 PM |
| Rabin Gary H | CEO & CFO | May 20, 2011 | Sale | $0.20 | 750,000 | 150,525 | 5,087,430 | Jun 03, 2011, 06:20 PM |
| Rabin Gary H | CEO & CFO | Mar 17, 2011 | Sale | $0.16 | 4,000 | 628 | 5,837,430 | May 25, 2011, 10:05 AM |
| Rabin Gary H | CEO & CFO | Mar 15, 2011 | Sale | $0.16 | 1,196,000 | 192,416 | 6,623,185 | May 25, 2011, 10:05 AM |
| Ruoslahti Erkki | Director | Mar 07, 2011 | Sale | $0.17 | 250,000 | 41,650 | 2,844,119 | Mar 08, 2011, 08:15 PM |
| Ruoslahti Erkki | Director | Mar 04, 2011 | Sale | $0.17 | 250,000 | 41,650 | 2,994,119 | Mar 08, 2011, 08:15 PM |
| Ruoslahti Erkki | Director | Mar 03, 2011 | Sale | $0.17 | 250,000 | 42,500 | 3,244,119 | Mar 07, 2011, 03:57 PM |
| Ruoslahti Erkki | Director | Mar 01, 2011 | Sale | $0.18 | 10,630 | 1,866 | 3,494,119 | Mar 03, 2011, 06:44 PM |
| Ruoslahti Erkki | Director | Feb 28, 2011 | Sale | $0.17 | 250,000 | 43,750 | 3,504,749 | Mar 01, 2011, 08:16 PM |
| Ruoslahti Erkki | Director | Feb 25, 2011 | Sale | $0.17 | 72,050 | 12,609 | 3,754,749 | Mar 01, 2011, 08:16 PM |
| Ruoslahti Erkki | Director | Feb 18, 2011 | Sale | $0.17 | 250,000 | 43,750 | 3,826,799 | Mar 01, 2011, 02:45 PM |
| Ruoslahti Erkki | Director | Feb 17, 2011 | Sale | $0.18 | 135,551 | 23,750 | 4,209,474 | Mar 01, 2011, 02:45 PM |
| Ruoslahti Erkki | Director | Feb 14, 2011 | Sale | $0.19 | 400,000 | 74,360 | 4,362,350 | Feb 18, 2011, 06:30 PM |
| Ruoslahti Erkki | Director | Feb 11, 2011 | Sale | $0.18 | 137,650 | 25,190 | 4,612,350 | Feb 15, 2011, 03:21 PM |
| Ruoslahti Erkki | Director | Feb 10, 2011 | Sale | $0.19 | 250,000 | 46,333 | 4,990,000 | Feb 15, 2011, 03:21 PM |
| Lanza Robert | Chief Scientific Officer | Dec 07, 2010 | Sale | $0.15 | 728,136 | 106,745 | 18,492,180 | Dec 08, 2010, 04:00 PM |
| Lanza Robert | Chief Scientific Officer | Dec 06, 2010 | Sale | $0.13 | 1,271,864 | 171,320 | 19,220,316 | Dec 08, 2010, 04:00 PM |
| Lanza Robert | Chief Scientific Officer | Nov 30, 2010 | Sale | $0.10 | 3,800,000 | 382,660 | 20,492,180 | Dec 01, 2010, 04:38 PM |
| Lanza Robert | Chief Scientific Officer | Nov 29, 2010 | Sale | $0.08 | 1,000,000 | 83,229 | 24,886,520 | Dec 01, 2010, 04:38 PM |
| Lanza Robert | Chief Scientific Officer | Nov 23, 2010 | Sale | $0.08 | 679,000 | 51,208 | 25,967,430 | Nov 24, 2010, 03:33 PM |
| Lanza Robert | Chief Scientific Officer | Nov 22, 2010 | Sale | $0.07 | 782,000 | 55,121 | 26,748,180 | Nov 24, 2010, 03:33 PM |
| Lanza Robert | Chief Scientific Officer | Sep 20, 2010 | Sale | $0.07 | 600,000 | 40,925 | 27,343,180 | Sep 22, 2010, 12:15 PM |
| Lanza Robert | Chief Scientfic Officer | Aug 20, 2010 | Sale | $0.08 | 600,000 | 45,197 | 27,862,480 | Aug 23, 2010, 05:11 PM |
| Lanza Robert | Chief Scientific Officer | Jul 21, 2010 | Sale | $0.07 | 102,850 | 7,200 | 27,953,180 | Jul 23, 2010, 12:13 PM |
| Lanza Robert | Chief Scientific Officer | Jul 20, 2010 | Sale | $0.07 | 497,150 | 35,090 | 28,547,630 | Jul 23, 2010, 12:13 PM |
| Lanza Robert | Chief Scientific Officer | Jul 21, 2010 | Sale | $0.07 | 205,700 | 14,399 | 27,953,180 | Jul 22, 2010, 01:22 PM |
| Lanza Robert | Chief Scientific Officer | Jul 20, 2010 | Sale | $0.07 | 994,300 | 70,180 | 28,547,630 | Jul 22, 2010, 01:22 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Lanza Robert | Chief Scientific Officer | 02/10/2016 | 1,967,827 |
| Myles Edward H | COO & CFO | 02/10/2016 | 476,000 |
| PERRY GREGORY D | Director | 02/10/2016 | 182,045 |
| LEVY BRIAN | Director | 02/10/2016 | 106,250 |
| Jooste H Le Roux | SVP of Bus Development & CCO | 02/10/2016 | 212,500 |
| SHAPIRO ALAN C | Director | 02/10/2016 | 2,407,761 |
| Anglade Eddy | Chief Medical Officer | 02/10/2016 | 476,000 |
| Heffernan Michael Thomas | Director | 02/10/2016 | 263,500 |
| LOSHITZER ZOHAR | Director | 02/10/2016 | 185,589 |
| LANGER ROBERT | Director | 02/10/2016 | 433,500 |
| Wotton Paul K | President and CEO | 02/10/2016 | 2,358,750 |
| Lanza Robert | Chief Scientific Officer | 11/10/2015 | 290,950 |
| Wotton Paul K | President and CEO | 07/30/2015 | 137,475 |
| Lanza Robert | Chief Scientific Officer | 09/10/2014 | 111,900 |
| Lanza Robert | Chief Scientific Officer | 09/08/2014 | 150,700 |
| Lanza Robert | Chief Scientific Officer | 09/03/2014 | 90,000 |
| Lanza Robert | Chief Scientific Officer | 09/02/2014 | 126,250 |
| Lanza Robert | Chief Scientific Officer | 07/07/2014 | 59,600 |
| Lanza Robert | Chief Scientific Officer | 07/03/2014 | 60,400 |
| Rabin Gary H | CEO & CFO | 02/07/2011 | 48,700 |
| Rabin Gary H | CEO & CFO | 05/29/2012 | 1,960 |
| Rabin Gary H | CEO & CFO | 08/10/2011 | 21,940 |
| Rabin Gary H | CEO & CFO | 10/23/2012 | 45,565 |
| Rabin Gary H | CEO & CFO | 01/23/2012 | 109,500 |
| Rabin Gary H | CEO & CFO | 05/25/2012 | 6,440 |
| Rabin Gary H | CEO & CFO | 08/09/2011 | 110,322 |
| Rabin Gary H | CEO & CFO | 10/22/2012 | 25,025 |
| Rabin Gary H | CEO & CFO | 10/14/2011 | 104,389 |
| Rabin Gary H | CEO & CFO | 05/24/2012 | 7,666 |
| Rabin Gary H | CEO & CFO | 05/04/2011 | 51,938 |
| Rabin Gary H | CEO & CFO | 09/06/2012 | 32,098 |
| Rabin Gary H | CEO & CFO | 10/13/2011 | 111,657 |
| Rabin Gary H | CEO & CFO | 05/14/2012 | 26,584 |
| Rabin Gary H | CEO & CFO | 04/26/2011 | 130,126 |
| Rabin Gary H | CEO & CFO | 09/05/2012 | 50,023 |
| Rabin Gary H | CEO & CFO | 10/12/2011 | 71,388 |
| Rabin Gary H | CEO & CFO | 05/11/2012 | 20,793 |
| Rabin Gary H | CEO & CFO | 02/28/2011 | 68,072 |
| Rabin Gary H | CEO & CFO | 08/27/2012 | 78,400 |
| Rabin Gary H | CEO & CFO | 08/12/2011 | 91,690 |
| Rabin Gary H | CEO & CFO | 05/07/2012 | 9,821 |
| Rabin Gary H | CEO & CFO | 02/09/2011 | 47,225 |
| Rabin Gary H | CEO & CFO | 06/15/2012 | 25,375 |
| Rabin Gary H | CEO & CFO | 08/11/2011 | 115,956 |
| Rabin Gary H | CEO & CFO | 01/10/2013 | 79,200 |
| Rabin Gary H | CEO & CFO | 05/03/2012 | 16,653 |
| Lanza Robert | Chief Scientific Officer | 12/14/2012 | 78,617 |
| Lanza Robert | Chief Scientific Officer | 12/14/2012 | 78,617 |
| Lanza Robert | Chief Scientific Officer | 07/31/2012 | 40,000 |
| Lanza Robert | Chief Scientific Officer | 07/30/2012 | 120,942 |
| Rabin Gary H | CEO & CFO | 06/11/2012 | 13,127 |
| Rabin Gary H | CEO & CFO | 06/14/2012 | 25,095 |
| Rabin Gary H | CEO & CFO | 06/13/2012 | 21,240 |
| Lanza Robert | Chief Scientific Officer | 01/24/2012 | 1,277,728 |
| Lanza Robert | Chief Scientific Officer | 01/23/2012 | 175,400 |
| Lanza Robert | Chief Scientific Officer | 09/29/2011 | 93,058 |
| Lanza Robert | Chief Scientific Officer | 09/28/2011 | 17,840 |
| Lanza Robert | Chief Scientific Officer | 06/21/2011 | 37,500 |
| Rabin Gary H | CEO & CFO | 05/20/2011 | 150,525 |
| Rabin Gary H | CEO & CFO | 03/17/2011 | 628 |
| Rabin Gary H | CEO & CFO | 03/15/2011 | 192,416 |
| Ruoslahti Erkki | Director | 03/07/2011 | 41,650 |
| Ruoslahti Erkki | Director | 03/04/2011 | 41,650 |
| Ruoslahti Erkki | Director | 03/03/2011 | 42,500 |
| Ruoslahti Erkki | Director | 03/01/2011 | 1,866 |
| Ruoslahti Erkki | Director | 02/28/2011 | 43,750 |
| Ruoslahti Erkki | Director | 02/25/2011 | 12,609 |
| Ruoslahti Erkki | Director | 02/18/2011 | 43,750 |
| Ruoslahti Erkki | Director | 02/17/2011 | 23,750 |
| Ruoslahti Erkki | Director | 02/14/2011 | 74,360 |
| Ruoslahti Erkki | Director | 02/11/2011 | 25,190 |
| Ruoslahti Erkki | Director | 02/10/2011 | 46,333 |
| Lanza Robert | Chief Scientific Officer | 12/07/2010 | 106,745 |
| Lanza Robert | Chief Scientific Officer | 12/06/2010 | 171,320 |
| Lanza Robert | Chief Scientific Officer | 11/30/2010 | 382,660 |
| Lanza Robert | Chief Scientific Officer | 11/29/2010 | 83,229 |
| Lanza Robert | Chief Scientific Officer | 11/23/2010 | 51,208 |
| Lanza Robert | Chief Scientific Officer | 11/22/2010 | 55,121 |
| Lanza Robert | Chief Scientific Officer | 09/20/2010 | 40,925 |
| Lanza Robert | Chief Scientfic Officer | 08/20/2010 | 45,197 |
| Lanza Robert | Chief Scientific Officer | 07/21/2010 | 7,200 |
| Lanza Robert | Chief Scientific Officer | 07/20/2010 | 35,090 |
| Lanza Robert | Chief Scientific Officer | 07/21/2010 | 14,399 |
| Lanza Robert | Chief Scientific Officer | 07/20/2010 | 70,180 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...